Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal syndrome classically
encountered in patients receiving typical antipsychotic agents. However, many physicians …

Most of the toxic agents (the so-called poisons) cause central and/or peripheral neurotoxic
effects. In the diagnostic process of many of the acute neurological syndromes, it is …

Neuroleptic malignant syndrome (NMS) was first described in the 1960s after the
introduction of the dopamine receptor-blocking antipsychotic agents. Any drug with this …

It is important to recognize that various serotonergic agents are involved in the CYP450
system. Inhibition of the CYP450 pathway by common antibiotics such as ciprofloxacin, or …

Savvy Psychopharmacology precursor to NMS. 4 Malignant (lethal) catatonia also closely
resembles NMS, and some consider NMS a variant of malignant catatonia or drug-induced …

Nöroleptik malign sendrom (NMS) antipsikotik ilaç kullanımı sonrasında ortaya çıkabilen
ciddi bir klinik tablodur. Antipsikotik kullanan tüm hastalarda dozdan bağımsız olarak …

Antipsychotics and antiemetics are commonly prescribed medications across medical
specialties. Antipsychotics are used to manage conditions such as psychosis …

Catatonia is a neuropsychiatric disorder affecting movement, speech and complex
behaviour. There is no unified theory of the pathophysiology of catatonia and concepts …

Discussion Although some cases of quetiapine-induced NMS have already been published,
most had several limitations and short follow-up periods. 4 Our patient presented the classic …

Introducción: el síndrome neuroléptico maligno es una urgencia neurológica,
potencialmente mortal, asociada de forma idiosincrásica al uso de agentes antipsicóticos …